Cardiovascular case study: Global Phase III Study – Heart Failure & Actigraphy
18 May 2017
After case studies about autoimmune & skin diseases, psoriasis and oncology, Kayentis releases its cardiovascular case study regarding heart failure and actigraphy. Kayentis offers combined eCOA / ePRO expertise in cardiovascular and medical device.
Global Phase III study – Cardiovascular & heart failure
- 600 patients
- 150 sites
- 20 countries
- 26 languages
Challenges of the cardiovascular case study
- An eCOA partner that could deliver an ePRO solution combined with proven data management and actigraphy expertise.
- On-site ePRO solution and data management of actigraphy data.
- Short study set-up timelines and interaction with the sponsor and different CROs for study implementation.
Frédérique MARION, Kayentis Business Development Director – May, 18, 2017
To download this case study, please click here:
Last update: 2018, January